Hikma Pharmaceuticals Plc (HIK)

https://pbs.twimg.com/media/HMdNURwWEAArYuf?format=jpg&name=small

$103 per share: Analysts at The Motley Fool weigh the short-term pullback outlook due to heavy capital dilution and growth targets that are difficult to sustain.

$98 per share: Fair value estimate cited by corporate finance experts, such as Professor Aswath Damodaran of New York University.

CYBL

WPP

TER

TIPS RVSN

AIBT

STEK

RDAR

I mean, that wine trap guy he signed on two years ago that scammed everyone along with Frank was such a loser. He went into foreclosure. He was trying to rent out his mansion that he was belly up in. And I guess nobody was renting that outdated POS and it got foreclosed on. Lol along with the roofin

I mean, that wine trap guy he signed on two years ago that scammed everyone along with Frank was such a loser. He went into foreclosure. He was trying to rent out his mansion that he was belly up in. And I guess nobody was renting that outdated POS and it got foreclosed on. Lol along with the roofin

AITX

NXGB

TRDW

GCTK

NKE

BGM

This thing has literally done nothing but dish out restricted stock that gets unrestricted and dumped the price does nothing but steadily decline. There’s never been anything good with this company. There’s never been anything real but again I’m a liar.

UMAV

NVVE

RGBPP

IZM

CLNV

MPU